SCHEMBL6586007

SCHEMBL6586007

CNC(=O)N1CCC(CN2CCC(N)CC2)CC1

nearest known ligand 0.49

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.47
MAPT P10636 6/20 0.46
GAA P10253 1/20 0.45
THRB P10828 6/20 0.44
TP53 P04637 1/20 0.43
LMNA P02545 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13208402 0.86 POLB (0.62) POLBLMNA
SCHEMBL6584534 0.83 CXCR3 (0.45) MAPTGAATHRBLMNA
SCHEMBL6585893 0.83 HTR4 (0.43) POLBMAPTGAATHRBLMNA
SCHEMBL6585178 0.81 SMN1; SMN2 (0.42) MAPTGAATHRBTP53LMNA
SCHEMBL6586735 0.79 MAPT (0.44) MAPTGAA
SCHEMBL6584309 0.79 SMN1; SMN2 (0.51) POLBMAPTGAATHRBTP53
SCHEMBL6587099 0.78 FAAH (0.62) MAPTGAATHRBTP53LMNA
SCHEMBL14450743 0.78 POLB (0.56) POLBMAPTLMNA
SCHEMBL6586716 0.77 SMN1; SMN2 (0.54) MAPTGAATHRBTP53LMNA
SCHEMBL7839825 0.77 HTR1A (0.46) POLBMAPTTHRBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1076055-B1 1- (1-SUBSTITUTED-4-PIPERIDINYL)METHYL]-4-PIPERIDINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, MEDICINAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATES OF THESE COMPOUNDS DAINIPPON PHARMACEUTICAL CO (JP) 2004-11-24 EP disclosed
US-6294555-B1 SEROTONIN HT3 RECEPTOR ANTAGONIST FOR GASTROINTESTINAL DISORDERS DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2001-09-25 US disclosed
EP-1076055-A1 1- (1-SUBSTITUTED-4-PIPERIDINYL)METHYL]-4-PIPERIDINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, MEDICINAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATES OF THESE COMPOUNDS Dainippon Pharmaceutical Co., Ltd. (JP) 2001-02-14 EP disclosed